Blume Capital Management’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.79M Buy
44,323
+44,185
+32,018% +$3.09M 0.41% 59
2026
Q1
$10.4K Sell
138
-31,953
-100% -$2.28M ﹤0.01% 272
2025
Q4
$1.98M Hold
32,091
0.36% 58
2025
Q3
$1.88M Buy
32,091
+350
+1% +$20.4K 0.36% 54
2025
Q2
$1.85M Sell
31,741
-55
-0.2% -$3.11K 0.37% 52
2025
Q1
$1.58M Buy
31,796
+220
+0.7% +$11.3K 0.35% 55
2024
Q4
$1.41M Buy
31,576
+13,005
+70% +$617K 0.32% 59
2024
Q3
$893K Buy
18,571
+1,005
+6% +$48.4K 0.2% 64
2024
Q2
$894K Buy
17,566
+439
+3% +$24K 0.22% 60
2024
Q1
$930K Buy
17,127
+1,290
+8% +$67.2K 0.22% 61
2023
Q4
$892K Buy
+15,837
New +$895K 0.23% 61

Other funds holding NTR

Blume Capital Management's NTR Position: Q2 2026 in Review

Blume Capital Management increased its Nutrien (NTR) stake by 32,018% in Q2 2026, buying an estimated $3.09M and bringing the position to 44,323 shares worth $2.79M. The position accounts for 0.41% of the portfolio, ranked #59.

Blume Capital Management first reported a position in NTR in Q4 2023 and has held it in 11 quarters since. 731 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Blume Capital Management held 44,323 shares of Nutrien worth $2.79M as of Q2 2026.
  • Blume Capital Management bought 44,185 Nutrien shares in Q2 2026, an estimated $3.09M.
  • Nutrien made up 0.41% of Blume Capital Management's portfolio in Q2 2026, its #59 holding.
  • Blume Capital Management first reported a position in Nutrien in Q4 2023 and has held it in 11 quarters since.
  • 731 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Blume Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.